Oral Oncology
Volume 37, Issue 1 , Pages 77-83 , January 2001

Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release

  • H. Ishibashi

      Affiliations

    • Second Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Graduate School of Medical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-0054, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-92-642-6452; fax: 81-92-642-6392
  • ,
  • T. Shiratuchi

      Affiliations

    • Second Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Graduate School of Medical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-0054, Japan
  • ,
  • K. Nakagawa

      Affiliations

    • Pathophysiological and Experimental Pathology, Department of Pathology, Graduate School of Medical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-0054, Japan
  • ,
  • M. Onimaru

      Affiliations

    • Second Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Graduate School of Medical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-0054, Japan
    • Pathophysiological and Experimental Pathology, Department of Pathology, Graduate School of Medical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-0054, Japan
  • ,
  • T. Sugiura

      Affiliations

    • Second Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Graduate School of Medical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-0054, Japan
  • ,
  • K. Sueishi

      Affiliations

    • Pathophysiological and Experimental Pathology, Department of Pathology, Graduate School of Medical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-0054, Japan
  • ,
  • K. Shirasuna

      Affiliations

    • Second Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Graduate School of Medical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-0054, Japan

Received 9 May 2000 ,Accepted 19 May 2000.

References 

  1. Folkman J. Tumor angiogenesis factor. Cancer Res. 1974;34:2109–2113
  2. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst. 1990;288:551–556
  3. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671–674
  4. Folkman J, Klagsbrun M. Angiogenic Factors. 1987;235:442–447
  5. Perrella MA, Jain MK, Lee ME. Role of TGF-beta in vascular development and vascular reactivity. Miner Electrol Metab. 1998;24:136–143
  6. Hu GF. Neomycin inhibits angiogenin-induced angiogenesis. Proc Nat Acad Sci. 1998;95:9791–9795
  7. Petit AM, Rak J, Hung MC, Rockwell P, Goldstein N, Fendly B, et al.  Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol. 1997;151:1523–1530
  8. Zhai Y, Yu J, Iruela-Arispe L, Huang WQ, Wang Z, Hayes AJ, et al.  Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily. Int J Cancer. 1999;82:131–136
  9. Lindahl P, Bostrom H, Karlsson L, Hellstrom M, Kalen M, Betsholtz C. Role of platelet-derived growth factors in angiogenesis and alveogenesis. Current Topics in Pathology. 1999;93:27–33
  10. Arii S, Mori A, Uchida S, Fujimoto K, Shimada Y, Imamura M. Implication of vascular endothelial growth factor in the development and metastasis of human cancers. Human Cell. 1999;12:25–30
  11. Bellamy WT, Richter L, Frutiger Y, Grogan TM. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Research. 1999;59:728–733
  12. Frank S, Stallmeyer B, Kampfer H, Kolb N, Pfeilschifter J. Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J. 1999;13:2002–2014
  13. Maruyama K, Mori Y, Murasawa S, Masaki H, Takahashi N, Tsutsumi Y, et al.  Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases. J Mol Cell Cardio. 1999;31:607–617
  14. Simpson DA, Murphy GM, Bhaduri T, Gardiner TA, Archer DB, Stitt AW. Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia. BBRC. 1999;262:333–334
  15. Schweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843–845
  16. Shibuya M, Yamaguchi S, Yamane A, Ideda T, Tojo A, Matsusima H, et al.  Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 1990;5:519–524
  17. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene. 1991;6:1677–1683
  18. Im SA, Gomez MC, Fueyo J, Liu TJ, Ke LD, Kim JS, et al.  Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo. Cancer Res. 1999;59:895–900
  19. Kanai T, Konno H, Tanaka T, Baba M, Matsumoto K, Nakamura S, et al.  Anti-tumor and anti-metastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice. Int J Cancer. 1998;77:933–936
  20. Goldman CK. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc Natl Acad Sci USA. 1998;95:8795–8800
  21. Rak J, Kerbel RS. bFGF and tumor angiogenesis — back in the limelight?. Nature Med. 1997;3:1083–1084
  22. Ishibashi H, Nakagawa K, Nakashima Y, Sueishi K. Conditioned media of carcinoma cells cultured in hypoxic microenvironment stimulate angiogenesis in vitro: relationship to basic fibroblast growth factor. Virchows Archiv. 1995;425:561–568
  23. Grunstein J, Roberts WG, Mathieu-Costello O, Hanahan D, Johnson RS. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res. 1999;59:1592–1598
  24. Shirasuna K, Watatani K, Furusawa H, Saka M, Morioka S, Oka H, et al.  Biological characterization of pseudocyst-forming cell lines from human adenoid cystic carcinomas of minor salivary gland origin. Cancer Res. 1990;50:4139–4151
  25. Ishibashi H, Tokudome S, Kurokawa H, Kajiyama M. Angiogenic factors of cultured oral carcinoma cells. Jpn J Oral Maxillofac Surg. 1995;41:389–395
  26. Holland EC, Varmus HE. Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proc Nat Acad Sci USA. 1998;95:1218–1223
  27. Myoken Y, Myoken Y, Okamoto T, Kan M, McKeeghan W, Sato JD, et al. Expression of fibroblast growth factor-1 (FGF-1), FGF-2 and FGF receptor-1 in a human salivary gland adenocarcinoma cell line; evidence of autocrine manner. Int J Cancer. 1996;65:650–657
  28. Azuma M, Yuki T, Motegi K, Sato M. Enhancement of bFGF export associated with malignant progression of human salivary gland cell clones. Int J Cancer. 1997;71:891–896
  29. Mignatti P, Morimoto P, Rifkin DB. Basic fibroblast growth factor. A protein devoid of secretory signal sequence is released by cells via a pathway independent of endoplasmic reticulum-Golgi complex. J Cell Physiol. 1992;151:81–93
  30. Czubayko F, Smith RV, Chung HC, Wellstein A. Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J Biol Chem. 1991;266:28243–28248
  31. Rupec RA, Baeuerle PA. The genomic response of tumor cells to hypoxia and reoxygenation differential activation of transcription factors AP-1 and NF-kB. Eur J Biochem. 1995;234:632–640
  32. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarwicz D, Fiddes JC, et al.  The human gene for vascular endothelial growth factor. J Biol Chem. 1997;13:11947–11954

PII: S1368-8375(00)00062-2

Oral Oncology
Volume 37, Issue 1 , Pages 77-83 , January 2001